GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we handle type 2 diabetes . These injectable medications work by imitating the body’s inherent https://socialfactories.com/story7272048/glp-1-a-significant-advance-in-glucose-care